South Korean E-cig Company Viento Launches New Disposable "V-Stick Change 1300"

Market by 2FIRSTS.ai

Jul.01.2024

South Korean E-cig Company Viento Launches New Disposable "V-Stick Change 1300"

South Korean e-cigarette company Viento launches new disposable product "V-Stick Change 1300" with improved features and lower cost.

According to the South Korean media outlet N. News, on July 1st, the South Korean e-cigarette company Viento announced the launch of the disposable e-cigarette "V-Stick Change 1300".

After being launched last year for three months, the product gained popularity in the market, ranking first in e-cigarette sales at Emart, a chain supermarket in South Korea, due to its high-quality performance and low maintenance costs.

This new product uses rechargeable batteries and only requires the replacement of disposable pods. Compared to integrated designs, its maintenance costs are lower. The liquid capacity has been increased from the original 1.2 milliliters to 3 milliliters, while the price has been further reduced, allowing for up to 1300 puffs.

"V-Stick Change 1300" has first launched its two best-selling flavors, Ice Purple and Ice Blue, and will begin selling them at GS25 and E-Mart 24 supermarkets nationwide starting this month.

References:

[1] 일회용 전자담배 '비스틱 체인지 1300' 출시…"용량 올리고 가격은 낮추고"

Also Read:

[1] China's E-cigarette Export Data to South Korea in May 2024

[2] South Korean Tobacco Company KT&G to Halt "ESSE Change Icefall"

[3] BAT Introduces VUSE GO 2.0 in South Korea with 6 New Flavors

[4] Haka Korea Launches Innovative E-cigarette "Haka H" for Pre-order

[5] BAT Rothmans Launches Initiative to Protect Minors from Nicotine Products

[6] Expansion of Smart Smoking Rooms in Seoul's Dong District

[7] BAT Glo HYPER Released Pro Version with Advanced Features

#Asia #Disposable e-cigarettes #Products #South Korea

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

ARAC to 2Firsts | FDA’s Nicotine Pouch Pilot: What Hasn’t Changed Matters Most

In a contribution to 2Firsts, U.S. regulatory consultancy ARAC analyzes the FDA’s nicotine pouch PMTA pilot, cautioning that core evidentiary standards remain unchanged. The firm warns against overinterpreting the pilot and urges companies to act now rather than wait for uncertain regulatory shifts.

Oct.21

Imperial Brands Urges Retailers to Engage in Government Consultation on Tobacco and Vapes Bill

Imperial Brands is calling on UK retailers to take part in the Government’s consultation on the Tobacco and Vapes Bill, which will shape a new licensing framework for nicotine product sales across England, Wales and Northern Ireland. The Department of Health and Social Care’s call for evidence closes on 3 December 2025. Imperial Brands stresses this is a key chance for retailers to influence policy, support fair competition, and help curb illicit sales.

Nov.04

Belgian Drug Commissioner Warns of Hidden Opioids in Illegal Vapes

Belgium’s drug commissioner Ine Van Wymersch has warned that more than 80% of illegal refillable vape capsules seized in Belgium contain synthetic opioids, posing serious risks of early addiction among children. She told Euronews that these substances, which have no distinctive smell or color, could lead to opioid dependence from a young age.

Dec.08 by 2FIRSTS.ai

Products | VAPORESSO Unveils Two New 10 mL Pod Devices for UK and US E-Commerce Channels

VAPORESSO has recently launched two new open-system vaping devices. The XROS 5 Nano is the first to roll out across UK and US online channels, featuring 30W output and a touch-screen design, while the ECO NANO Plus has gone live on the brand’s official website with a 10 mL high-capacity pod and a 1400 mAh battery.